Macrolide antibiotic
Clarithromycin
Brand names: Klaricid, Klaricid XL
Adult dose
Dose: PO 250–500mg BD; XL 500mg OD. IV 500mg BD
Route: PO/IV
Frequency: BD
Paediatric dose
Dose: 7.5 mg/kg
Route: PO
Frequency: BD
Max: 500mg/dose
Concentration: 25 mg/ml
Standard 7.5 mg/kg BD; severe infections up to 15 mg/kg/day
Dose adjustments
Renal
CrCl <30: halve dose
Paediatric weight-based calculator
Standard 7.5 mg/kg BD; severe infections up to 15 mg/kg/day
Clinical pearls
- First-line CAP penicillin-allergic; H. pylori eradication component
- ECG if cardiac risk; many CYP3A4 interactions
Contraindications
- History of QT prolongation
- With ergot alkaloids
- Concurrent astemizole/cisapride/domperidone (potent CYP3A4 inhibition)
- Severe hepatic impairment + renal impairment
Side effects
- GI upset
- Taste disturbance
- QT prolongation
- Hepatotoxicity
- C. difficile
- Worsening myasthenia gravis
Interactions
- Major: simvastatin/atorvastatin (myopathy — avoid)
- Warfarin (raised INR)
- Colchicine (toxicity)
- Digoxin
- Tacrolimus/ciclosporin
- Direct oral anticoagulants
Monitoring
- LFTs if prolonged
- ECG if QT risk
Reference: BNFc; BNF; NICE CKS; https://bnf.nice.org.uk/drugs/clarithromycin/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- FeverPAIN Score for Strep Throat · Throat
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- PID Severity (CDC Diagnostic Criteria) · Gynaecological Infections
- Gustilo-Anderson Classification (Open Fractures) · Fracture Classification
- DRIP Score for Drug-Resistant Pneumonia · Pneumonia
Drugs
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023